Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoffman

Showing results (41-50 of 204) with videos related to

Pageof 21
Sort By:
Cell|July 28, 2018
Whirling Platelets Away for TransfusionCamelia Iancu-Rubin, Ronald Hoffman, Anna Rita Migliaccio
Frontiers in Oncology|March 5, 2021
Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential ThrombocythemiaDouglas Tremblay, Heidi E Kosiorek, Amylou C Dueck, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2013
Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasiaJyoti Malhotra, Marina Kremyanskaya, Emily Schorr, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2020
Ex Vivo Expansion of Adult Hematopoietic Stem and Progenitor Cells with Valproic AcidLuena Papa, Mansour Djedaini, Manisha Kintali, et al.
Blood|May 30, 2014
The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cellsMin Lu, Lijuan Xia, Yan Li, et al.
Leukemia Research|May 29, 2018
Outcomes and predictors of survival in blast phase myeloproliferative neoplasmsGuido Lancman, Andrew Brunner, Ronald Hoffman, et al.
The Laryngoscope|February 3, 2004
Surgical management of complications after hearing aid fittingDarius Kohan, Alexander Sorin, Stephen Marra, et al.
Oncology (Williston Park, N.Y.)|August 28, 2013
Clarifying the use of ruxolitinib in patients with myelofibrosisMarina Kremyanskaya, Ehab L Atallah, Ronald Hoffman, et al.
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Clinical and laboratory features of myelofibrosis and limitations of current therapiesStephanie A Gregory, Ruben A Mesa, Ronald Hoffman, et al.
The Journal of Clinical Investigation|April 26, 2014
Epigenetic reprogramming induces the expansion of cord blood stem cellsPratima Chaurasia, David C Gajzer, Christoph Schaniel, et al.
Pageof 21

Showing results (41-50 of 204) with videos related to

Sort By:
Pageof 21
Cell|July 28, 2018
Whirling Platelets Away for TransfusionCamelia Iancu-Rubin, Ronald Hoffman, Anna Rita Migliaccio
Frontiers in Oncology|March 5, 2021
Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential ThrombocythemiaDouglas Tremblay, Heidi E Kosiorek, Amylou C Dueck, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 14, 2013
Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasiaJyoti Malhotra, Marina Kremyanskaya, Emily Schorr, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2020
Ex Vivo Expansion of Adult Hematopoietic Stem and Progenitor Cells with Valproic AcidLuena Papa, Mansour Djedaini, Manisha Kintali, et al.
Blood|May 30, 2014
The orally bioavailable MDM2 antagonist RG7112 and pegylated interferon α 2a target JAK2V617F-positive progenitor and stem cellsMin Lu, Lijuan Xia, Yan Li, et al.
Leukemia Research|May 29, 2018
Outcomes and predictors of survival in blast phase myeloproliferative neoplasmsGuido Lancman, Andrew Brunner, Ronald Hoffman, et al.
The Laryngoscope|February 3, 2004
Surgical management of complications after hearing aid fittingDarius Kohan, Alexander Sorin, Stephen Marra, et al.
Oncology (Williston Park, N.Y.)|August 28, 2013
Clarifying the use of ruxolitinib in patients with myelofibrosisMarina Kremyanskaya, Ehab L Atallah, Ronald Hoffman, et al.
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Clinical and laboratory features of myelofibrosis and limitations of current therapiesStephanie A Gregory, Ruben A Mesa, Ronald Hoffman, et al.
The Journal of Clinical Investigation|April 26, 2014
Epigenetic reprogramming induces the expansion of cord blood stem cellsPratima Chaurasia, David C Gajzer, Christoph Schaniel, et al.
Pageof 21